Highlights
- 1Nature · 2021
- 2
- 3Methods in enzymology · 2019
Publications
74 publications
Funding
23 grantsView NIH portfolio on RePORTER ↗
Active
16 grants- Co-IThe role of MGA in the pathogenesis of Richter TransformationNational Cancer Institute · 2026–2031
- Co-ISPORE: Adressing Health Disparities in LymphomaNational Cancer Institute · 2025–2030 · via MD Anderson Cancer Center· 3 renewalsU54CA302435-01
- Co-ITargeting the melanoma metabolic microenvironment to boost T-cell therapyMelanoma Research Alliance · 2026–20291584423
- PIImproving immunotherapy by modulating PD-1hiFoxp3-CD4+ T cells in melanomaMelanoma Research Foundation · 2026–2028MRF 261760-01
- PIEffects of tumor energetics on anti-tumor immunity through vasculature remodelingThe G. Harold and Leila Y. Mathers Foundation · 2025–2028GHL 251782-02
- PITargeting MALT1 to Enhance Anti-Lymphoma Immunity and Response to ImmunotherapyNational Cancer Institute · 2023–2028· 2 renewalsR01CA282889-04
- Co-IPICI Grant and Main Collaboration Agreement with Multiple SubprojectsParker Institute for Cancer Immunotherapy · 2024–2028PICI 235170-03
- MPITargeting Unmet Needs For B-cell LymphomasLeukemia & Lymphoma Society · 2022–2027LLS 7027-23 Project 1
- Co-IElucidating the Role of the Tumor Suppressor KEAP1 in Antitumor ImmunityNational Cancer Institute · 2025–2027
- PIMechanisms of "fragile" intratumoral regulatory T cells supporting anti-tumor immunityCancer Research Institute, Inc. · 2025–2027CRI13928
- MPIResearch Collaboration Agreement- Treeline Biosciences, Inc.Treeline Biosciences INC · 2024–2027BioPharma AllianceBP 240939-02
- PIProstate Cancer Non-Neuroendocrine Lineage Plasticity: Detection Using Multimodal Integration And immunotherapeutic TargetingStarr Cancer Consortium · 2024–2026I17-0132
- MPIEpigenetic basis and therapeutic targeting of the unique lymphoma immunological nicheNational Cancer Institute · 2024–2026P01CA272295-02
- PICD36 in breast cancerPilatus Biosciences Inc · 2025–2026ContractSRA 234221-01
- Co-ICOG Hodgkin Lymphoma (Defining Biomarkers of Response to Immunotherapy in Pediatric Hodgkin Lymphoma - The Jeffrey Pride Foundation Integrated Correlative Biology Awards)Jeffrey Pride Foundation INC · 2024–2026 · via Children's Oncology GroupNY018_2024_01_ROTH
- PIInvestigating the tumor metabolism-hypoxia-vasculature axis in the response of TNBC to immunotherapyFondazione AIRC per la Ricerca sul Cancro · 2024–2026No publications yetFAIRC 232007-02
Completed grants (7)
- PIRestoring lymphoma immunosurveillance by combined EZH2 inhibition and immunotherapy.Leukemia & Lymphoma Society · 2021–2025LLS 6643-22
- MPITargeting immune escape in Cluster 5 DLBCLAstraZeneca Pharmaceuticals LP · 2021–2025ContractSRA 215352-02
- PITumor-metabolism-driven therapies to overcome TNBC immune resistanceBreast Cancer Alliance Inc. · 2023–2025BCA 225494-02
- PISRA with BMSBristol-Myers Squibb · 2021–2024ContractSRA 215059-02
- KPHypoxic incubator for physiological cell culture researchOffice of the Director, NIH · 2022–2023S10OD032317-01
- PIDissecting the role of CD4+ TFH-like cells as a therapeutic target and biomarker of immunotherapy activityParker Institute for Cancer Immunotherapy · 2020–2022ContractSRA 203365-02
- MPIImmune Crosstalk In Non-Hodgkin B-Cell Lymphomas As A Therapeutic VulnerabilityNational Cancer Institute · 2020–2022 · via Memorial Sloan Kettering Cancer CenterP50CA192937-05
Clinical research
1 study
Active
1 study- PIAI Digital Pathology Tools to Improve Lymphoma Diagnosis and ClassificationMD Anderson Cancer Center · OPEN TO ACCRUAL (as of 2026)
News mentions
1 mentionView all WCM news ↗
- New Starr Cancer Consortium Grants Awarded to Weill Cornell Medicine ResearchersOctober 30, 2024
Three teams led by Weill Cornell Medicine scientists have received awards from the Starr Cancer Consortium in its 17th and final annual grant competition
Mentoring
7 menteesAll publications with mentees →
- JHJee Hye KangImmunology & Microbial Pathogenesis (PhD)
- MRMarc-Anthony RodriguezMD mentee · Class of 2025
- JYJuan YuPostdoc mentee · 2025–2026
External relationships
Other
iTeos Therapeutics